// App-Quantinova.ai

BS25 : TAM receptor AXL loss regulates smooth muscle cell differentiation and accelerates atherosclerosis in mice

Researchers

Presenter

  • Lucy Mcshane

Principal Investigators

  • Danila Gurgone

  • Abdullatif Mohammed Bin-Khunayn

  • Eva Crespo

  • Gianluca Grassia

  • Neil MacRitchie

  • Mauro Giacca

  • Lorena Zentilin

  • Glykeria Karadimou

  • Gabrielle Paulsson-Berne

  • Peder S Olofsson

  • Thomas D Otto

  • Tomasz J Guzik

  • Mariola Kurowska-Stolarska

  • Pasquale Maffia

Medical Centers

  • Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

  • School of Cardiovascular Medicine & Sciences, King’s College London British Heart Foundation Centre

  • Center for Molecular Medicine, Karolinska Institutet

  • Molecular Medicine Laborator, International Centre for Genetic Engineering and Biotechnology-ICGEB, Trieste, Italy

  • Institute of Cardiovascular and Medical Sciences, The University of Glasgow

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • AXL receptor tyrosine kinase

  • Proprotein convertase subtilisin/kexin type 9

  • Stromal interaction molecule 1

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved